The News
Angel Yeast (SH600298) participated in Vitafoods Europe 2026 from May 5–7 in Barcelona. The company unveiled AngeoPro™ S80-A, a high-purity yeast protein with ≥80% protein content that is 100% soluble and clear. The product was demonstrated through transparent functional waters, RTD beverages, and high-protein ice cream without dairy or lactose.
Angel Yeast’s unveiling of AngeoPro™ at Vitafoods Europe 2026 signals a shift toward the fastest‑growing segment of ready‑to‑drink (RTD) protein beverages. For distributors and brand managers, it is an opportunity to add a science‑backed, fully soluble ingredient that can meet EU health‑claim standards while fitting into the growing RTD portfolio.
The company presented AngeoPro™ at the May 5–7 event in Barcelona, positioning the S80‑A variant as a clear, ≥80 % protein ingredient that dissolves without sediment. The product’s clinical data cover muscle and skeletal health, exercise performance, intestinal health and weight management—claims that align with the 23 % approval rate for EU health dossiers between 2020 and 2025.
In March 2026 Angel Yeast announced two AngeoPro variants: Hi90‑A (88 % protein) aimed at sports nutrition and S80‑A for RTD beverages. A new production line in Baiyang Biotechnology Park, commissioned November 2025, adds more than 10 000 t of annual yeast‑protein capacity to meet rising demand.
The broader market context is clear: the global functional‑food market was $285.2 bn in 2025 and is growing at a 7.1 % CAGR; RTD sports drinks are projected to grow 12.5 % annually, outpacing overall beverage growth. Meanwhile, only 3.2 % of plant‑based protein sales grew year‑on‑year in 2025, indicating consumer fatigue with existing options.
For distributors, the key takeaways are:
- Regulatory readiness – Angel Yeast’s clinical backing gives AngeoPro™ a distinct advantage over competitors that lack robust EU dossiers.
- Production scale – The new line’s 10 000 t capacity means suppliers can source the ingredient without bottlenecks or costly imports, supporting larger RTD rollouts.
- Portfolio fit – With its full solubility and clarity, AngeoPro™ can replace whey or soy in chilled, plant‑based protein shakes, aligning with consumers’ demand for clean labels.
In practice, bars and retailers can view AngeoPro™ as a premium protein source that justifies higher price points while simplifying formulation. Its 100 % solubility eliminates the need for clarification steps, potentially lowering production costs for manufacturers adopting it. Distributors can market the ingredient with robust health‑claim language that meets EU regulations, appealing to health‑conscious consumers—a differentiator hard to replicate without similar clinical evidence.
Overall, Angel Yeast’s launch of AngeoPro™ at Vitafoods Europe 2026 offers industry players a concrete tool to tap into the growing RTD protein market while navigating stringent regulatory requirements and leveraging significant production capacity.
Original Press Release
Angel Yeast (SH600298), the world's leading manufacturer of yeast and yeast protein, has participated in Vitafoods Europe 2026, the premier global nutrition and health exhibition, on May 5–7 at the Fira de Barcelona. The company highlights its patented technology breakthrough AngeoPro Yeast Protein, alongside a comprehensive portfolio of functional ingredients designed to address global challenges in sustainable nutrition, sports performance, and holistic wellness.
Scientific Innovation Meets Market Demand
The centerpiece of Angel Yeast's exhibition was the unveiling of AngeoPro™, a high-purity yeast protein solution designed to address the formulation challenges prevalent in the sports nutrition and functional beverage sectors.
Unlike conventional proteins, AngeoPro™ S80-A is distinguished by its ≥80% protein content and unique physical properties. It offers a revolutionary advantage for beverage manufacturers: it is 100% soluble and clear with complete amino acids profile. This allows for the creation of transparent, high-protein functional waters and RTD (Ready-to-Drink) beverages without the cloudiness or sedimentation.
Visitors sampled multi-flavored yeast protein beverages that showcased the ingredient's unique clarity and nutrition, alongside high-protein ice cream that delivered creamy textures without dairy and lactose. A selection of gourmet protein-rich foods was also on display, proving that high-performance protein can seamlessly integrate into everyday consumption experiences.
Backed by published scientific studies, the product's efficacy has been rigorously validated. Clinical data highlighted AngeoPro™'s multifaceted health benefits, including support for Muscle & Skeletal Health, Exercise Performance, Intestinal Health, and Weight Management. This robust scientific dossier provides European formulators with the evidence-based validation required for health claims in the stringent EU regulatory environment.
This comprehensive health portfolio positions AngeoPro™ as a versatile solution for sports nutrition, medical foods, and weight management formulations.
Executive Insight: Bridging the Protein Gap
During the exhibition, Dr. Sun, Global product manager of Angel Yeast, delivered a keynote address titled "A New Choice for Muscle Health: Yeast Protein—An Ideal Option for Next-Generation Sports Nutrition." In his presentation, Dr. Sun emphasized the sustainability and performance advantages of fermentation-derived proteins.
"The future of protein is not just about quantity, but quality and sustainability. Through our AngeoPro™ technology, we are bridging the gap between the high performance demanded by athletes and the clean, transparent textures demanded by modern consumers. Fermentation offers a path to produce complete proteins with a full amino acid profile and a dramatically lower carbon footprint than traditional agriculture. We are not just launching a product; we are offering a sustainable, science-backed solution for the next generation of functional foods."
Driving Sustainable Nutrition
Aligned with the European market's demand for nutrition and wellness, beyond its flagship protein innovation, Angel Yeast showcased a comprehensive portfolio tailored to Europe's diverse health needs, including Sports Nutrition with Vitamin K2 (MK-7) and Tea Ingredients, Immune Support utilizing Yeast Beta-Glucans and Postbiotics, Gut Health solutions featuring Saccharomyces boulardii, and specialized ingredients for Antioxidant and Cardiovascular health like Glutathione Yeast and Fermented Ginseng.
Strategic Outlook
This participation in Vitafoods Europe served as a critical platform for Angel Yeast to align its R&D roadmap with the specific demands of the European market. By engaging with international industry leaders, the company has solidified its commitment to providing "Yeast-Powered Nutrition for Performance, Wellness, & Vitality."
Angel Yeast remains dedicated to driving innovation in the health ingredient sector, leveraging fermentation technology to meet the rising global demand for sustainable, high-performance nutrition.
Photo - https://mma.prnewswire.com/media/2975507/20260508111846.jpgLogo - https://mma.prnewswire.com/media/1586948/angel_logo_Logo.jpg
Sources consulted (web research):
- 354676959
- Angel Yeast At Vitafoods Europe 2026 Pioneering Global Nutrition And…
- Quality Protein No Longer A Luxury Angel Yeast Shows How At Fic 2026…
- News 22158061
- Angel Yeast En Vitafoods Europe 2026 Pionera Con La Proteina De Levad…
- Angel Yeast A Vitafoods Europe 2026 Pionnier Des Tendances Mondiales…
Source: PR Newswire